Logo image of QSI

QUANTUM-SI INC (QSI) Stock Fundamental Analysis

NASDAQ:QSI - Nasdaq - US74765K1051 - Common Stock - Currency: USD

1.765  +0.08 (+5.06%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to QSI. QSI was compared to 55 industry peers in the Life Sciences Tools & Services industry. While QSI has a great health rating, there are worries on its profitability. QSI is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

QSI had negative earnings in the past year.
QSI had a negative operating cash flow in the past year.
In the past 5 years QSI always reported negative net income.
QSI had a negative operating cash flow in each of the past 5 years.
QSI Yearly Net Income VS EBIT VS OCF VS FCFQSI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

QSI has a Return On Assets of -37.14%. This is in the lower half of the industry: QSI underperforms 78.18% of its industry peers.
With a Return On Equity value of -40.79%, QSI is not doing good in the industry: 67.27% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -37.14%
ROE -40.79%
ROIC N/A
ROA(3y)-35.58%
ROA(5y)-43.16%
ROE(3y)-39.71%
ROE(5y)-48.09%
ROIC(3y)N/A
ROIC(5y)N/A
QSI Yearly ROA, ROE, ROICQSI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60 -80 -100

1.3 Margins

QSI has a Gross Margin (52.77%) which is in line with its industry peers.
The Profit Margin and Operating Margin are not available for QSI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 52.77%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
QSI Yearly Profit, Operating, Gross MarginsQSI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K -8K

More info and screens

8

2. Health

2.1 Basic Checks

QSI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for QSI has been increased compared to 1 year ago.
There is no outstanding debt for QSI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
QSI Yearly Shares OutstandingQSI Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 50M 100M 150M
QSI Yearly Total Debt VS Total AssetsQSI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2.2 Solvency

QSI has an Altman-Z score of 4.14. This indicates that QSI is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.14, QSI is in the better half of the industry, outperforming 78.18% of the companies in the same industry.
QSI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.14
ROIC/WACCN/A
WACC10.17%
QSI Yearly LT Debt VS Equity VS FCFQSI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

2.3 Liquidity

QSI has a Current Ratio of 19.24. This indicates that QSI is financially healthy and has no problem in meeting its short term obligations.
QSI has a Current ratio of 19.24. This is amongst the best in the industry. QSI outperforms 98.18% of its industry peers.
A Quick Ratio of 18.89 indicates that QSI has no problem at all paying its short term obligations.
QSI's Quick ratio of 18.89 is amongst the best of the industry. QSI outperforms 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 19.24
Quick Ratio 18.89
QSI Yearly Current Assets VS Current LiabilitesQSI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

4

3. Growth

3.1 Past

The earnings per share for QSI have decreased by -4.62% in the last year.
Looking at the last year, QSI shows a very strong growth in Revenue. The Revenue has grown by 167.52%.
EPS 1Y (TTM)-4.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
Revenue 1Y (TTM)167.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%84.25%

3.2 Future

The Earnings Per Share is expected to grow by 10.65% on average over the next years. This is quite good.
Based on estimates for the next years, QSI will show a very strong growth in Revenue. The Revenue will grow by 123.57% on average per year.
EPS Next Y13.7%
EPS Next 2Y9.48%
EPS Next 3Y12.06%
EPS Next 5Y10.65%
Revenue Next Year73.82%
Revenue Next 2Y147.12%
Revenue Next 3Y149.34%
Revenue Next 5Y123.57%

3.3 Evolution

QSI Yearly Revenue VS EstimatesQSI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M 250M
QSI Yearly EPS VS EstimatesQSI Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 -0.2 -0.4 -0.6 -0.8

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for QSI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for QSI. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
QSI Price Earnings VS Forward Price EarningsQSI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
QSI Per share dataQSI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

A more expensive valuation may be justified as QSI's earnings are expected to grow with 12.06% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y9.48%
EPS Next 3Y12.06%

More info and screens

0

5. Dividend

5.1 Amount

QSI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

QUANTUM-SI INC

NASDAQ:QSI (6/18/2025, 11:47:57 AM)

1.765

+0.08 (+5.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)05-15 2025-05-15/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners30.88%
Inst Owner Change8.21%
Ins Owners5.65%
Ins Owner Change8.35%
Market Cap323.88M
Analysts77.14
Price Target2.89 (63.74%)
Short Float %17.27%
Short Ratio3.42
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.49%
Min EPS beat(2)-21.99%
Max EPS beat(2)28.97%
EPS beat(4)3
Avg EPS beat(4)8.05%
Min EPS beat(4)-21.99%
Max EPS beat(4)28.97%
EPS beat(8)7
Avg EPS beat(8)12.15%
EPS beat(12)10
Avg EPS beat(12)8.65%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.91%
Min Revenue beat(2)-12.03%
Max Revenue beat(2)-3.79%
Revenue beat(4)0
Avg Revenue beat(4)-13.25%
Min Revenue beat(4)-27.8%
Max Revenue beat(4)-3.79%
Revenue beat(8)2
Avg Revenue beat(8)-13.59%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-16.26%
PT rev (3m)-17.07%
EPS NQ rev (1m)6.67%
EPS NQ rev (3m)6.67%
EPS NY rev (1m)0%
EPS NY rev (3m)15.35%
Revenue NQ rev (1m)-23.95%
Revenue NQ rev (3m)-23.95%
Revenue NY rev (1m)-29.31%
Revenue NY rev (3m)-30.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 94.07
P/FCF N/A
P/OCF N/A
P/B 1.31
P/tB 1.31
EV/EBITDA N/A
EPS(TTM)-0.68
EYN/A
EPS(NY)-0.57
Fwd EYN/A
FCF(TTM)-0.52
FCFYN/A
OCF(TTM)-0.49
OCFYN/A
SpS0.02
BVpS1.35
TBVpS1.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -37.14%
ROE -40.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 52.77%
FCFM N/A
ROA(3y)-35.58%
ROA(5y)-43.16%
ROE(3y)-39.71%
ROE(5y)-48.09%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 108.71%
Cap/Sales 140.69%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 19.24
Quick Ratio 18.89
Altman-Z 4.14
F-Score4
WACC10.17%
ROIC/WACCN/A
Cap/Depr(3y)214.69%
Cap/Depr(5y)249.92%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-4.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%21.43%
EPS Next Y13.7%
EPS Next 2Y9.48%
EPS Next 3Y12.06%
EPS Next 5Y10.65%
Revenue 1Y (TTM)167.52%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%84.25%
Revenue Next Year73.82%
Revenue Next 2Y147.12%
Revenue Next 3Y149.34%
Revenue Next 5Y123.57%
EBIT growth 1Y-6.62%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year10.28%
EBIT Next 3Y5.81%
EBIT Next 5Y9.27%
FCF growth 1Y11.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y5.51%
OCF growth 3YN/A
OCF growth 5YN/A